bay h 2049 has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atassi, G; Dumont, P; Kabbe, HJ; Yoder, O | 1 |
1 other study(ies) available for bay h 2049 and B16 Melanoma
Article | Year |
---|---|
A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Leukemia L1210; Leukemia P388; Melanoma, Experimental; Mice; Quinazolines | 1988 |